Delay in Diagnostic Workup and Treatment of Esophageal Cancer
Esophageal cancer should preferably be detected and treated at an early stage, but this may be prohibited by late onset of symptoms and delays in referral, diagnostic workup, and treatment. The aim of this study was to investigate the impact of these delays on outcome in patients with esophageal cancer.
For 491 patients undergoing esophagectomy for cancer between 1991 and 2007, patients’ short- and long-term outcome were analyzed according to different time intervals between onset of symptoms, diagnosis, and surgical treatment.
Length of prehospital delay (from onset of symptoms until endoscopic diagnosis) did not affect patient’s short- or long-term outcome. A shorter hospital delay between establishing the diagnosis of esophageal cancer on endoscopy and surgery was associated with lower overall morbidity and in-hospital mortality. Patients of ASA classes I and II experienced a shorter hospital delay than patients of ASA classes III and IV. Length of hospital delay between endoscopic diagnosis and surgery did not affect pathological tumor–node–metastasis stage or R0-resection rate. Longer hospital delay did not result in worse survival: Overall survival after esophagectomy for cancer was not significantly different between patients with hospital delay <5, 5–8, or >8 weeks (24.7%, 21.7%, and 32.3%, respectively; p = 0.12).
A longer hospital delay (between endoscopic diagnosis and surgery) resulted in worse patient’s short-term outcome (higher overall morbidity and mortality rates) but not in a worse long-term outcome (overall survival). This may be explained by a more time-consuming diagnostic workup in patients with a poorer physical status and not by tumor progression.
- Lerut T, De Leyn P, Coosemans W et al. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992;216(5):583–590. CrossRef
- Siewert JR, Stein HJ, Feith M et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001;234(3):360–367. (discussion 368–369). CrossRef
- Hulscher JB, van Sandick JW, de Boer AG et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347(21):1662–1669. CrossRef
- Eloubeidi MA, Desmond R, Arguedas MR et al. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002;95(7):1434–1443. CrossRef
- Wijnhoven BP, Tran KT, Esterman A et al. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 2007;245(5):717–725. CrossRef
- Richards MA, Westcombe AM, Love SB et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999;353(9159):1119–1126. CrossRef
- Ramos M, Esteva M, Cabeza E et al. Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer 2007;43(17):2467–2478. CrossRef
- Ramos M, Esteva M, Cabeza E et al. Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer. Eur J Cancer 2008;44(4):510–521. CrossRef
- Wang J, Liu F, Gao H et al. The symptom-to-treatment delay and stage at the time of treatment in cancer of esophagus. Jpn J Clin Oncol 2008;38(2):87–91. CrossRef
- Kotz BS, Croft S, Ferry DR. Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? A study based on West Midlands cancer registration data. Br J Cancer 2006;95(7):835–840. CrossRef
- Rothwell JF, Feehan E, Reid I et al. Delay in treatment for oesophageal cancer. Br J Surg 1997;84(5):690–693. CrossRef
- Martin IG, Young S, Sue-Ling H, Johnston D. Delays in the diagnosis of oesophagogastric cancer: a consecutive case series. BMJ 1997;314(7079):467–470.
- Witzig R, Schonberger B, Fink U et al. Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma. Endoscopy 2006;38(11):1122–1126. CrossRef
- Kok TC, Van Lanschot JJB, Siersema PD et al. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial. Proc Am Soc Clin Oncol 1997;17:984.
- van Heijl M, van Lanschot JJ, Koppert LB et al. Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS). BMC Surg 2008;8:21. CrossRef
- Omloo JM, Lagarde SM, Hulscher JB et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007;246(6):992–1000. (discussion 1000–1001). CrossRef
- Sobin L. TNM classification of malignant tumors, 6th edn. Wiley: New York, 2002.
- Visser MR, van Lanschot JJ, van der Velden J et al. Quality of life in newly diagnosed cancer patients waiting for surgery is seriously impaired. J Surg Oncol 2006;93(7):571–577. CrossRef
- Logan RF, Behan MW, Campion G, Keating NA. Impact of the two-week referral guideline on time to diagnosis and treatment in oesophago-gastric cancer. Clin Med 2003;3(4):386–387.
- Spahos T, Hindmarsh A, Cameron E et al. Endoscopy waiting times and impact of the two week wait scheme on diagnosis and outcome of upper gastrointestinal cancer. Postgrad Med J 2005;81(961):728–730. CrossRef
- Rachet B, Maringe C, Nur U et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 2009;10(4):351–369. CrossRef
- Delay in Diagnostic Workup and Treatment of Esophageal Cancer
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Journal of Gastrointestinal Surgery
Volume 14, Issue 3 , pp 476-483
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Esophageal cancer
- Diagnostic workup
- Waiting list
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands
- 3. Erasmus Medical Center, Department of Surgery, PO Box 2040, 3000 CA, Rotterdam, The Netherlands
- 2. Department of Gastroenterology, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands